Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands

Elife. 2021 Jun 28:10:e65184. doi: 10.7554/eLife.65184.

Abstract

G-quadruplexes (G4) are non-canonical DNA structures found in the genome of most species including human. Small molecules stabilizing these structures, called G4 ligands, have been identified and, for some of them, shown to induce cytotoxic DNA double-strand breaks. Through the use of an unbiased genetic approach, we identify here topoisomerase 2α (TOP2A) as a major effector of cytotoxicity induced by two clastogenic G4 ligands, pyridostatin and CX-5461, the latter molecule currently undergoing phase I/II clinical trials in oncology. We show that both TOP2 activity and transcription account for DNA break production following G4 ligand treatments. In contrast, clastogenic activity of these G4 ligands is countered by topoisomerase 1 (TOP1), which limits co-transcriptional G4 formation, and by factors promoting transcriptional elongation. Altogether our results support that clastogenic G4 ligands act as DNA structure-driven TOP2 poisons at transcribed regions bearing G4 structures.

Keywords: CX-5461; DNA breaks; G-quadruplex; cancer biology; chromosomes; gene expression; human; topoisomerase 2; transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoquinolines / pharmacology*
  • Antineoplastic Agents / pharmacology*
  • Benzothiazoles / pharmacology*
  • Cell Line
  • Cell Proliferation
  • Cell Survival / drug effects
  • Colony-Forming Units Assay
  • DNA Breaks, Double-Stranded
  • DNA Topoisomerases, Type I / genetics
  • DNA Topoisomerases, Type I / metabolism
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism*
  • G-Quadruplexes
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • Naphthyridines / pharmacology*
  • Picolinic Acids / pharmacology*
  • Poly-ADP-Ribose Binding Proteins / genetics
  • Poly-ADP-Ribose Binding Proteins / metabolism*
  • Polymorphism, Single Nucleotide
  • RNA Interference
  • RNA-Seq

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Benzothiazoles
  • CX 5461
  • Naphthyridines
  • Picolinic Acids
  • Poly-ADP-Ribose Binding Proteins
  • pyridostatin
  • DNA Topoisomerases, Type I
  • TOP1 protein, human
  • DNA Topoisomerases, Type II
  • TOP2A protein, human

Grants and funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.